Skip to main content
Erschienen in: International Urology and Nephrology 5/2018

02.04.2018 | Urology - Original Paper

Elevated visceral obesity quantified by CT is associated with adverse postoperative outcome of laparoscopic radical nephrectomy for renal clear cell carcinoma patients

verfasst von: Tingshuai Zhai, Bocheng Zhang, Zhenan Qu, Chen Chen

Erschienen in: International Urology and Nephrology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To examine the association between CT measures of visceral obesity and short-term postoperative outcomes in renal clear cell carcinoma (RCCC) patients.

Methods

In this retrospective study, 76 patients treated with unilateral laparoscopic radical nephrectomy for stage I–III renal cancer were classified as obese or non-obese by preoperative CT-based measures of adiposity [obese: visceral fat area (VFA) > 100 cm2, BMI ≥ 28 kg/m2]. Clinical variables, Fuhrman grade, operation time, estimated blood loss (EBL), postoperative complications, postoperative stay, drainage time and hospitalization expenses were compared between the two groups.

Results

Viscerally obese patients significantly had higher Fuhrman grade than the non-obese (p = 0.018). The operation time of obese patients by VFA or BMI was more than the non-obese (171.6 ± 68.9 vs. 140.8 ± 35.5 min, p = 0.012 and 197.2 ± 67.2 vs. 153.2 ± 57.7 min, p = 0.013, respectively). And obese patients by VFA or BMI tended to have more EBL than non-obese (132.0 ± 120.7 vs. 83.8 ± 53.4 ml, p = 0.018 and 215.3 ± 165.0 vs. 92.5 ± 68.8 ml, p = 0.013, respectively). Viscerally obese patients by VFA (not BMI) were more likely to develop postoperative complications as compared to patients classified as non-obese: VFA (26.9 vs. 4.2%, p = 0.045) and BMI (33.3 vs. 16.4%, p =0.265). Furthermore, obese patients by VFA (not BMI) were more likely to have longer postoperative stay: VFA (8.7 ± 2.5 vs. 7.5 ± 1.4 dollars, p = 0.013) and BMI (9.1 ± 2.9 vs. 8.1 ± 2.1 dollars, p = 0.209). Obese patients expensed more than non-obese: VFA (7570.9 ± 2674.3 vs. 6368.8 ± 1289.8 dollars, p = 0.040) and BMI (8390.8 ± 2929.7 vs. 6896.3 ± 2159.1 dollars, p = 0.029).

Conclusions

Elevated visceral obesity by VFA is associated with increased surgical complexity, postoperative morbidity, postoperative stay and hospitalization expenses for RCCC patients and may be superior to BMI for renal cancer outcome assessment. VFA may be a useful index for the evaluation and calculation of RCCC aggressiveness.
Literatur
1.
Zurück zum Zitat Ozoya OO, Siegel EM, Srikumar T et al (2017) Quantitative assessment of visceral obesity and postoperative colon cancer outcomes. Gastrointest Surg 21(3):534–542CrossRef Ozoya OO, Siegel EM, Srikumar T et al (2017) Quantitative assessment of visceral obesity and postoperative colon cancer outcomes. Gastrointest Surg 21(3):534–542CrossRef
2.
Zurück zum Zitat Yuge K, Miyajima A, Jinzaki M et al (2015) How does visceral obesity affect surgical performance in laparoscopic radical nephrectomy? Jpn J Clin Oncol 45(4):373–377CrossRefPubMed Yuge K, Miyajima A, Jinzaki M et al (2015) How does visceral obesity affect surgical performance in laparoscopic radical nephrectomy? Jpn J Clin Oncol 45(4):373–377CrossRefPubMed
3.
Zurück zum Zitat Keehn A, Srivastava A, Maiman R et al (2015) The relationship between visceral obesity and the clinicopathologic features of patients with small renal masses. J Endourol 29(3):372–376CrossRefPubMed Keehn A, Srivastava A, Maiman R et al (2015) The relationship between visceral obesity and the clinicopathologic features of patients with small renal masses. J Endourol 29(3):372–376CrossRefPubMed
4.
Zurück zum Zitat Irving BA, Weltman JY, Brock DWNIH et al (2007) ImageJ and Slice-O-Matic computed tomography imaging software to quantify soft tissue. Obesity (Silver Spring) 15(2):370–376CrossRef Irving BA, Weltman JY, Brock DWNIH et al (2007) ImageJ and Slice-O-Matic computed tomography imaging software to quantify soft tissue. Obesity (Silver Spring) 15(2):370–376CrossRef
5.
Zurück zum Zitat Sobin LH, Gospodariwicz M, Wittekind C (eds) (2009) TNM classification of malignant tumors. UICC International Union Against Cancer, vol 7. Wiley-Blackwell, Hoboken, p 255 Sobin LH, Gospodariwicz M, Wittekind C (eds) (2009) TNM classification of malignant tumors. UICC International Union Against Cancer, vol 7. Wiley-Blackwell, Hoboken, p 255
6.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Jeong IG, Khandwala YS, Kim JH et al (2017) Association of robotic-assisted vs laparoscopic radical nephrectomy with perioperative outcomes and health care costs, 2003 to 2015. JAMA 318(16):1561–1568CrossRefPubMedPubMedCentral Jeong IG, Khandwala YS, Kim JH et al (2017) Association of robotic-assisted vs laparoscopic radical nephrectomy with perioperative outcomes and health care costs, 2003 to 2015. JAMA 318(16):1561–1568CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Tewari N, Awad S, Macdonald IA, Lobo DN (2015) Obesity-related insulin resistance: implications for the surgical patient. Int J Obes (Lond) 39(11):1575–1588CrossRef Tewari N, Awad S, Macdonald IA, Lobo DN (2015) Obesity-related insulin resistance: implications for the surgical patient. Int J Obes (Lond) 39(11):1575–1588CrossRef
10.
Zurück zum Zitat Harvey AE, Lashinger LM, Hursting SD (2011) The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 1229:45–52CrossRefPubMed Harvey AE, Lashinger LM, Hursting SD (2011) The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 1229:45–52CrossRefPubMed
11.
Zurück zum Zitat Klöting N, Fasshauer M, Dietrich A et al (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299(3):E506–E515CrossRefPubMed Klöting N, Fasshauer M, Dietrich A et al (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299(3):E506–E515CrossRefPubMed
12.
Zurück zum Zitat Ye J, Gao Z, Yin J et al (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293(4):E1118–E1128CrossRefPubMed Ye J, Gao Z, Yin J et al (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293(4):E1118–E1128CrossRefPubMed
13.
Zurück zum Zitat Qin L, Wang Z, Tao L et al (2010) ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy. Autophagy 6(2):239–247CrossRefPubMed Qin L, Wang Z, Tao L et al (2010) ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy. Autophagy 6(2):239–247CrossRefPubMed
14.
Zurück zum Zitat Pecorelli N, Carrara G, DeCobelli F et al (2016) Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg 103(4):434–442CrossRefPubMed Pecorelli N, Carrara G, DeCobelli F et al (2016) Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg 103(4):434–442CrossRefPubMed
15.
Zurück zum Zitat Hagiwara M, Miyajima A, Hasegawa M et al (2012) Visceral obesity is a strong predictor of perioperative outcome in patients undergoing laparoscopic radical nephrectomy. BJU Int 110(11 Pt C):E980-4PubMed Hagiwara M, Miyajima A, Hasegawa M et al (2012) Visceral obesity is a strong predictor of perioperative outcome in patients undergoing laparoscopic radical nephrectomy. BJU Int 110(11 Pt C):E980-4PubMed
16.
Zurück zum Zitat Ioffe E, Hakimi AA, Sk O et al (2013) Effect of visceral obesity on minimally invasive partial nephrectomy. Urology 82(3):612–618CrossRefPubMed Ioffe E, Hakimi AA, Sk O et al (2013) Effect of visceral obesity on minimally invasive partial nephrectomy. Urology 82(3):612–618CrossRefPubMed
17.
Zurück zum Zitat Zhu Y, Wang HK, Zhang HL et al (2013) Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma. J Urol 189(2):447–453CrossRefPubMed Zhu Y, Wang HK, Zhang HL et al (2013) Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma. J Urol 189(2):447–453CrossRefPubMed
18.
Zurück zum Zitat Kato M, Suzuki T, Suzuki Y et al (2004) Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol 172:863CrossRefPubMed Kato M, Suzuki T, Suzuki Y et al (2004) Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol 172:863CrossRefPubMed
19.
Zurück zum Zitat Guðmundsson E, Hellborg H, Lundstam S et al (2011) Metastatic potential in renal cell carcinomas ≤ 7 cm: Swedish kidney cancer quality register data. Eur Urol 60:975CrossRefPubMed Guðmundsson E, Hellborg H, Lundstam S et al (2011) Metastatic potential in renal cell carcinomas ≤ 7 cm: Swedish kidney cancer quality register data. Eur Urol 60:975CrossRefPubMed
20.
Zurück zum Zitat Khandekar MJ, Cohen P, Spiegelman BM et al (2011) Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11:886CrossRefPubMed Khandekar MJ, Cohen P, Spiegelman BM et al (2011) Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11:886CrossRefPubMed
22.
Zurück zum Zitat Ladoire S, Bonnetain F, Gauthier M et al (2011) Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents. Oncologist 16:71–81CrossRefPubMedPubMedCentral Ladoire S, Bonnetain F, Gauthier M et al (2011) Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents. Oncologist 16:71–81CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Yerlikaya A, Dagel T, King C et al (2017) Dietary and commercialized fructose: Sweet or sour? Int Urol Nephrol 49:1611CrossRefPubMed Yerlikaya A, Dagel T, King C et al (2017) Dietary and commercialized fructose: Sweet or sour? Int Urol Nephrol 49:1611CrossRefPubMed
24.
Zurück zum Zitat Kadowaki T, Sekikawa A, Murata K et al (2006) Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study. Int J Obes (Lond) 30:1163CrossRef Kadowaki T, Sekikawa A, Murata K et al (2006) Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study. Int J Obes (Lond) 30:1163CrossRef
Metadaten
Titel
Elevated visceral obesity quantified by CT is associated with adverse postoperative outcome of laparoscopic radical nephrectomy for renal clear cell carcinoma patients
verfasst von
Tingshuai Zhai
Bocheng Zhang
Zhenan Qu
Chen Chen
Publikationsdatum
02.04.2018
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 5/2018
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-018-1858-1

Weitere Artikel der Ausgabe 5/2018

International Urology and Nephrology 5/2018 Zur Ausgabe

Response - Urology Letter

Re: Letter to the editor

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.